Propolis is one of 117 small molecule programs targeting Periodontitis. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
145 competitors in Efficacy
Rituxan
Oncovin
Biaxin
Adriamycin
Soliris
Alimta
Cytoxan
Lesinurad
Insulin 320
Zelhou
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details